204 related articles for article (PubMed ID: 1363705)
1. Pathological status and therapy of HIV-infected hemophiliacs in Japan.
Yamada K
Southeast Asian J Trop Med Public Health; 1992; 23 Suppl 2():127-30. PubMed ID: 1363705
[TBL] [Abstract][Full Text] [Related]
2. Progression to acquired immunodeficiency syndrome in 94 human immunodeficiency virus-positive hemophiliacs with long-term follow-up.
Lorenzo JI; Moscardó F; López-Aldeguer J; Aznar JA
Haematologica; 2001 Mar; 86(3):291-6. PubMed ID: 11357820
[TBL] [Abstract][Full Text] [Related]
3. [Progression to AIDS among HIV-seropositive hemophiliacs].
Lorenzo JI; Molina R; Senent ML; Monzó E; Lerma MA; Dasí MA; Monteagudo E; Aznar JA
Sangre (Barc); 1992 Jun; 37(3):169-74. PubMed ID: 1440093
[TBL] [Abstract][Full Text] [Related]
4. CD4 cells in HIV-1 infected hemophiliacs: effect of factor VIII concentrates.
Goldsmith JM; Deutsche J; Tang M; Green D
Thromb Haemost; 1991 Oct; 66(4):415-9. PubMed ID: 1839091
[TBL] [Abstract][Full Text] [Related]
5. The impact of antiviral therapy with zidovudine: a retrospective study on HIV-positive hemophiliacs in Italy. Italian Group of Congenital Coagulopathies.
Arcieri R; Puopolo M; Baudo F; Chiarotti F; De Rosa V; Schinaia N; Mori PG; Ghirardini A
Haematologica; 1995; 80(1):25-30. PubMed ID: 7758987
[TBL] [Abstract][Full Text] [Related]
6. High risk of acquired immune deficiency syndrome (AIDS) and of AIDS related complex (ARC) in hemophiliacs seropositive for more than 5 years.
Stain C; Pabinger-Fasching I; Guggenberger K; Köller U; Stain M; Hartl H; Heinz F; Mayerhofer S; Kyrle PA; Lechner K
Thromb Haemost; 1989 Jun; 61(3):354-6. PubMed ID: 2799750
[TBL] [Abstract][Full Text] [Related]
7. [The present status in prophylaxis and treatment of HIV infected patients with hemophilia in Japan].
Mori K; Sakai H; Suzuki S; Akutsu Y; Ishikawa M; Aihara M; Yokoyama M; Sato Y; Okaniwa S; Endo Y
Rinsho Byori; 1989 Nov; 37(11):1200-8. PubMed ID: 2689699
[TBL] [Abstract][Full Text] [Related]
8. Factors associated with progression to AIDS and mortality in a cohort of HIV-infected patients with hemophilia followed up since seroconversion.
Santagostino E; Gringeri A; Cultraro D; Tradati F; Siracusano L; Marinoni A; Mannucci PM
Cell Mol Biol (Noisy-le-grand); 1995 May; 41(3):371-80. PubMed ID: 7580830
[TBL] [Abstract][Full Text] [Related]
9. Spectrum of HIV infection and AIDS in a cohort of Italian hemophiliacs.
Sorice F; Ghirardini A; Martino P; Pasqualetti D; Annino L; Micozzi A; Cirelli A; Tamburrini E; Isacchi G; Buttò S
Haematologica; 1989; 74(2):149-54. PubMed ID: 2568323
[TBL] [Abstract][Full Text] [Related]
10. Clinical factors associated with progression to AIDS in the Italian cohort of HIV-positive hemophiliacs. G.I.C.C. Gruppo Italiano Coagulopatie Congenite.
Schinaia N; Ghirardini AM; Mazzucconi MG; Tagariello G; Morfini M; Chiarotti F
Thromb Haemost; 1994 Jul; 72(1):33-8. PubMed ID: 7974372
[TBL] [Abstract][Full Text] [Related]
11. AIDS studies in Japan.
Harada S; Yamamoto N
Jpn J Cancer Res; 1987 May; 78(5):415-27. PubMed ID: 3112053
[TBL] [Abstract][Full Text] [Related]
12. The incidence and prevalence of AIDS and prevalence of other severe HIV disease in England and Wales for 1995 to 1999: projections using data to the end of 1994.
Commun Dis Rep CDR Rev; 1996 Jan; 6(1):R1-21. PubMed ID: 8581117
[TBL] [Abstract][Full Text] [Related]
13. The impact of ethanol and Marinol/marijuana usage on HIV+/AIDS patients undergoing azidothymidine, azidothymidine/dideoxycytidine, or dideoxyinosine therapy.
Whitfield RM; Bechtel LM; Starich GH
Alcohol Clin Exp Res; 1997 Feb; 21(1):122-7. PubMed ID: 9046384
[TBL] [Abstract][Full Text] [Related]
14. CD4 surveillance in Scotland: perspectives on severe HIV-related immunodeficiency. CD4 Collaborative Group.
AIDS; 1997 Oct; 11(12):1509-17. PubMed ID: 9342074
[TBL] [Abstract][Full Text] [Related]
15. [Detection of HIV-1 proviral DNA and RNA in serum from HIV-1 sero-positive hemophiliacs by polymerase chain reaction].
Horikoshi Y; Ichikawa M; Tonouchi T; Mimaya J; Morita T; Ohtsuka Y; Kawabata H
Rinsho Ketsueki; 1993 May; 34(5):620-7. PubMed ID: 8315834
[TBL] [Abstract][Full Text] [Related]
16. Immune status of asymptomatic HIV-infected hemophiliacs: randomized, prospective, two-year comparison of treatment with a high-purity or an intermediate-purity factor VIII concentrate.
Mannucci PM; Gringeri A; de Biasi R; Baudo F; Morfini M; Ciavarella N
Thromb Haemost; 1992 Mar; 67(3):310-3. PubMed ID: 1353642
[TBL] [Abstract][Full Text] [Related]
17. Survival of patients receiving zidovudine before or after AIDS diagnosis: results of a German multicenter study. German AIDS Study Group.
Clin Investig; 1994 Jan; 72(2):111-6. PubMed ID: 8186655
[TBL] [Abstract][Full Text] [Related]
18. Concordance of human leukocyte antigen haplotype-sharing, CD4 decline and AIDS in hemophilic siblings. Multicenter Hemophilia Cohort and Hemophilia Growth and Development Studies.
Kroner BL; Goedert JJ; Blattner WA; Wilson SE; Carrington MN; Mann DL
AIDS; 1995 Mar; 9(3):275-80. PubMed ID: 7755916
[TBL] [Abstract][Full Text] [Related]
19. Zoster incidence in human immunodeficiency virus-infected hemophiliacs and homosexual men, 1984-1997. District of Columbia Gay Cohort Study. Multicenter Hemophilia Cohort Study.
Engels EA; Rosenberg PS; Biggar RJ
J Infect Dis; 1999 Dec; 180(6):1784-9. PubMed ID: 10558932
[TBL] [Abstract][Full Text] [Related]
20. Azidothymidine (AZT) in the treatment of symptomatic HIV-1-infected hemophiliacs.
Eichinger S; Pabinger I; Hartl H; Stain C; Mayerhofer S; Schweiger C; Kier P; Schwarzinger I; Kyrle PA; Lechner K
Thromb Haemost; 1990 Aug; 64(1):108-12. PubMed ID: 1980381
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
